Anti-VP6 VHH: An Experimental Treatment for Rotavirus A-Associated Disease

Species A Rotaviruses (RVA) remain a leading cause of mortality in children under 5 years of age. Current treatment options are limited. We assessed the efficacy of two VP6-specific llama-derived heavy chain antibody fragments (VHH) -2KD1 and 3B2- as an oral prophylactic and therapeutic treatment ag...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:PLoS One
Huvudupphovsmän: Maffey, Lucía, Vega, Celina G., Miño, Samuel, Garaicoechea, Lorena, Parreño, Viviana
Materialtyp: Artigo
Språk:Inglês
Publicerad: Public Library of Science 2016
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5014449/
https://ncbi.nlm.nih.gov/pubmed/27603013
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0162351
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk